This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
Intuit vs. PayPal: Which Fintech Stock Is the Better Buy Now?
by Rohit Vasant Fatarpekar
INTU's AI-driven ecosystem and TurboTax Live fuel growth, while PYPL's Venmo expansion and comprehensive payments and commerce solutions intensify the fintech battle.
INTUPositive Net Change PYPLPositive Net Change
fin-tech
SoFi's Expanding Ecosystem Highlights Strong Growth Momentum
by Zacks Equity Research
SOFI's rapid growth in members and products highlights strong ecosystem expansion despite recent weakness in its stock.
LCPositive Net Change UPSTPositive Net Change SOFIPositive Net Change
fin-tech finance
HOOD Stock Retreats After 2025 Rally: Should You Stay Invested?
by Swayta Shah
Robinhood drops 25% YTD after a huge 2025 run as crypto trading cools and valuation worries rise despite new AI tools and expansion plans. What should you do?
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
artificial-intelligence banking bitcoin cryptocurrency fin-tech finance
Block's Cash App: Can Banking Engagement Keep Scaling?
by Namrata Chandak
XYZ's Cash App banking push pays off as PBAs, inflows and lending rise, deepening engagement across its financial ecosystem.
PYPLPositive Net Change XYZPositive Net Change CHYMPositive Net Change
fin-tech
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ABCLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Cadence Design Systems (CDNS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CDNSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Block vs. Upstart: Which Is the Better Fintech Stock to Consider?
by Rohit Vasant Fatarpekar
XYZ's Cash App and Square fuel strong growth, while UPST's AI-driven lending and rapid loan expansion intensify the fintech battle.
UPSTPositive Net Change XYZPositive Net Change
fin-tech
Will UPST's Credit Union Partnerships Strengthen Its Lending Growth?
by Zacks Equity Research
Upstart expands its credit union network with Community Choice CU as funding capacity continue to grow.
ALRSNegative Net Change UPSTPositive Net Change CHYMPositive Net Change
fin-tech
HOOD Brings AI Agents to Trading and Spending: Opportunity or Risk?
by Swayta Shah
Robinhood rolls out AI agents for trading and Gold Card spending, adding safeguards, yet raising worries about errors, fraud and regulation.
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
cryptocurrency fin-tech finance
JFrog Ltd. (FROG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
FROGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines